Cargando…

Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer

Objective: Ras-related C3 botulinum toxin substrate1(Rac1) and epithelial mesenchymal transition (EMT) are key therapeutic targets in cancer. We investigated the clinical significance of Rac1 and markers of EMT expression in non-small cell lung cancer (NSCLC), and their possible correlation with EMT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yujuan, Liao, Qianjin, Han, Yaqian, Chen, Jie, Liu, Zhigang, Ling, Hang, Zhang, Jing, Yang, Wenjuan, Oyang, Linda, Xia, Longzheng, Wang, Li, Wang, Heran, Xue, Lei, Wang, Hui, Hu, Bingqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118674/ https://www.ncbi.nlm.nih.gov/pubmed/27877226 http://dx.doi.org/10.7150/jca.16198

Ejemplares similares

RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer
por: Tan, Shiming, et al.
Publicado: (2020)

Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer
por: Tan, Shiming, et al.
Publicado: (2020)

Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition
por: Xia, Longzheng, et al.
Publicado: (2019)

Overexpression of PAK1 Correlates with Aberrant Expression of EMT Markers and Poor Prognosis in Non-Small Cell Lung Cancer
por: Yang, Zhiying, et al.
Publicado: (2017)

High expression of calreticulin indicates poor prognosis and modulates cell migration and invasion via activating Stat3 in nasopharyngeal carcinoma
por: Han, Yaqian, et al.
Publicado: (2019)

Rac1, A Potential Target for Tumor Therapy
por: Liang, Jiaxin, et al.
Publicado: (2021)

GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Wang, Guifu, et al.
Publicado: (2020)

Exosomes in Nasopharyngeal Carcinoma
por: Zhou, Yujuan, et al.
Publicado: (2018)

Cancer stem cells in progression of colorectal cancer
por: Zhou, Yujuan, et al.
Publicado: (2017)

Role of the NFκB-signaling pathway in cancer
por: Xia, Longzheng, et al.
Publicado: (2018)

TRPV4 Overexpression Promotes Metastasis Through Epithelial–Mesenchymal Transition in Gastric Cancer and Correlates with Poor Prognosis
por: Wang, Huafeng, et al.
Publicado: (2020)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

Overexpression of RACK1 Promotes Metastasis by Enhancing Epithelial-Mesenchymal Transition and Predicts Poor Prognosis in Human Glioma
por: Lv, Qiao-Li, et al.
Publicado: (2016)

Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9
por: Liang, Jiaxin, et al.
Publicado: (2022)

Overexpression of long non-coding RNA CRNDE facilitates epithelial-mesenchymal transition and correlates with poor prognosis in intrahepatic cholangiocarcinoma
por: Xia, Xiu-Liang, et al.
Publicado: (2018)

Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition
por: Song, Tao, et al.
Publicado: (2018)

Overexpression of SPARC correlates with poor prognosis in patients with cervical carcinoma and regulates cancer cell epithelial-mesenchymal transition
por: SHI, DEHUAN, et al.
Publicado: (2016)

Overexpression of shugoshin1 predicts a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial–mesenchymal transition
por: Mu, Jiagui, et al.
Publicado: (2019)

Overexpression of stromal interaction molecule 1 may promote epithelial-mesenchymal transition and indicate poor prognosis in gastric cancer
por: Wu, Guobin, et al.
Publicado: (2017)

Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Ma, Wei, et al.
Publicado: (2022)

LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma
por: Wang, Heran, et al.
Publicado: (2019)

Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma
por: Zhang, Tong-Jun, et al.
Publicado: (2017)

Mastl overexpression is associated with epithelial to mesenchymal transition and predicts a poor clinical outcome in gastric cancer
por: Sun, Xian-Jun, et al.
Publicado: (2017)

RAB4A GTPase regulates epithelial-to-mesenchymal transition by modulating RAC1 activation
por: Karthikeyan, Subbulakshmi, et al.
Publicado: (2022)

Liver kinase B1 correlates with prognosis and epithelial-mesenchymal transition of resectable early stage non-small cell lung cancer
por: Qin, Zhaohui, et al.
Publicado: (2020)

Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer
por: Kurashige, Junji, et al.
Publicado: (2019)

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
por: Xu, Xuemeng, et al.
Publicado: (2023)

Overexpression of fibronectin type III domain containing 3B is correlated with epithelial-mesenchymal transition and predicts poor prognosis in lung adenocarcinoma
por: Bian, Tingting, et al.
Publicado: (2019)

RAC1B: A Guardian of the Epithelial Phenotype and Protector Against Epithelial-Mesenchymal Transition
por: Zinn, Rabea, et al.
Publicado: (2019)

CTHRC1 overexpression predicts poor survival and enhances epithelial‐mesenchymal transition in colorectal cancer
por: Ni, Shujuan, et al.
Publicado: (2018)

High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial–mesenchymal Transition
por: Pang, Zhaofei, et al.
Publicado: (2019)

High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial–mesenchymal transition in gastric cancer
por: Yan, Yan, et al.
Publicado: (2016)

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma
por: Zhang, Huan, et al.
Publicado: (2022)

Decreased chromobox homologue 7 expression is associated with epithelial–mesenchymal transition and poor prognosis in cervical cancer
por: Tian, Ping, et al.
Publicado: (2021)

Biological Function of HYOU1 in Tumors and Other Diseases
por: Rao, Shan, et al.
Publicado: (2021)

Organoids: opportunities and challenges of cancer therapy
por: Jiang, Xianjie, et al.
Publicado: (2023)

The function of prohibitins in mitochondria and the clinical potentials
por: Oyang, Linda, et al.
Publicado: (2022)

Clinical significance and integrative analysis of the cuproptosis-associated genes in head and neck squamous cell carcinoma
por: Peng, Qiu, et al.
Publicado: (2023)

Phase separation in Cancer: From the Impacts and Mechanisms to Treatment potentials
por: Peng, Qiu, et al.
Publicado: (2022)

Low expression of Rap1GAP is associated with epithelial-mesenchymal transition (EMT) and poor prognosis in gastric cancer
por: Yang, Ya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fm9ih02ufu9r5i2sb21402oshc